Advertisement

American Journal of Clinical Dermatology

, Volume 15, Issue 2, pp 101–113 | Cite as

Perioral Dermatitis: A Review of the Condition with Special Attention to Treatment Options

  • Therdpong TemparkEmail author
  • Tor A. Shwayder
Review Article

Abstract

Perioral dermatitis is a common acneiform facial eruption found in both adults and children. Its variants are periorificial and granulomatous periorificial dermatitis. The etiology of perioral dermatitis remains unknown; however, topical corticosteroid use on the face commonly precedes the manifestation of this condition. There are an overwhelming number of treatment options for perioral dermatitis, and the options in children are slightly different from those in adults for both systemic medications and topical treatment. This article provides a literature review of the various applicable treatments available based on the level and quality of the evidence by the US Preventive Service Task Force. Oral tetracycline reveals the best valid evidence. However, if the patient is less than 8 years old, then this oral therapy may not be suitable. Topical metronidazole, erythromycin, and pimecrolimus also represent effective treatment choices with good evidence. Topical corticosteroid use is common in these cases and the question of whether it is a good treatment or a cause remains unanswered. Corticosteroid cream can improve the clinical picture, but there is a risk of rebound when treatment is stopped. We propose a treatment algorithm to assist dermatologists, pediatric dermatologists, and general practitioners encountering this condition.

Keywords

Isotretinoin Topical Corticosteroid Pimecrolimus Rosacea Seborrheic Dermatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Statement of Funding

None.

Conflict of Interest Disclosures

Dr. Tor A. Shwayder: None.

Dr. Therdpong Tempark: None.

References

  1. 1.
    Nguyen V, Eichenfield LF. Periorificial dermatitis in children and adolescents. J Am Acad Dermatol. 2006;55(5):781–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Hafeez ZH. Perioral dermatitis: an update. Int J Dermatol. 2003;42(7):514–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Laude TA, Salvemini JN. Perioral dermatitis in children. Semin Cutan Med Surg. 1999;18(3):206–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Lipozencic J, Ljubojevic S. Perioral dermatitis. Clin Dermatol. 2011;29(2):157–61.PubMedCrossRefGoogle Scholar
  5. 5.
    Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1–15 quiz 6-8.PubMedCrossRefGoogle Scholar
  6. 6.
    Bradford LG, Montes LF. Perioral dermatitis and Candida albicans. Arch Dermatol. 1972;105(6):892–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Takiwaki H, Tsuda H, Arase S, Takeichi H. Differences between intrafollicular microorganism profiles in perioral and seborrhoeic dermatitis. Clin Exp Dermatol. 2003;28(5):531–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Hsu CK, Hsu MM, Lee JY. Demodicosis: a clinicopathological study. J Am Acad Dermatol. 2009;60(3):453–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Berardi P, Benvenuti S, Genga A, Cecchini F. Demonstration of fusobacteria in eruptions of perioral dermatitis using the tape stripping toluidine blue (TSTB) method. J Eur Acad Dermatol Venereol. 1994;3:495–9.CrossRefGoogle Scholar
  10. 10.
    Wells K, Brodell RT. Topical corticosteroid ‘addiction’. A cause of perioral dermatitis. Postgrad Med. 1993;93(5):225–30.PubMedGoogle Scholar
  11. 11.
    Shiri J, Amichai B. Perioral dermatitis induced by inhaled corticosteroids. J Dermatol Treat. 1998;9:259–60.CrossRefGoogle Scholar
  12. 12.
    Dubus JC, Marguet C, Deschildre A, Mely L, Le Roux P, Brouard J, et al. Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy. 2001;56(10):944–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Kumar P, Parashette KR, Noronha P. Letter: Perioral dermatitis in a child associated with an inhalation steroid. Dermatol Online J. 2010;16(4):13.PubMedGoogle Scholar
  14. 14.
    Clementson B, Smidt AC. Periorificial dermatitis due to systemic corticosteroids in children: report of two cases. Pediatr Dermatol. 2012;29(3):331–2.PubMedCrossRefGoogle Scholar
  15. 15.
    Mellette JR, Aeling JL, Nuss DD. Letter: Fluoride tooth paste: a cause of perioral dermatitis. Arch Dermatol. 1976;112(5):730–1.PubMedCrossRefGoogle Scholar
  16. 16.
    Ferlito TA. Tartar-control toothpaste and perioral dermatitis. J Clin Orthod. 1992;26(1):43–4.PubMedGoogle Scholar
  17. 17.
    Abele DC. ‘Moisturizers’ and perioral dermatitis. Arch Dermatol. 1977;113(1):110.PubMedCrossRefGoogle Scholar
  18. 18.
    Malik R, Quirk CJ. Topical applications and perioral dermatitis. Australas J Dermatol. 2000;41(1):34–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Abeck D, Geisenfelder B, Brandt O. Physical sunscreens with high sun protection factor may cause perioral dermatitis in children. J Dtsch Dermatol Ges. 2009;7(8):701–3.PubMedGoogle Scholar
  20. 20.
    Guarneri F, Marini H. An unusual case of perioral dermatitis: possible pathogenic role of neurogenic inflammation. J Eur Acad Dermatol Venereol. 2007;21(3):410–2.PubMedCrossRefGoogle Scholar
  21. 21.
    Rallis G, Papakosta V, Petrakogiannis C, Zachariades N. Perioral dermatitis following orthognathic surgery. Plast Reconstr Surg. 2004;113(2):771–3.PubMedCrossRefGoogle Scholar
  22. 22.
    Satyawan I, Oranje AP, van Joost T. Perioral dermatitis in a child due to rosin in chewing gum. Contact Dermat. 1990;22(3):182–3.CrossRefGoogle Scholar
  23. 23.
    Jansen T. Perioral dermatitis successfully treated with topical adapalene. J Eur Acad Dermatol Venereol. 2002;16(2):175–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Dirschka T, Szliska C, Jackowski J, Tronnier H. Impaired skin barrier and atopic diathesis in perioral dermatitis. J Dtsch Dermatol Ges. 2003;1(3):199–203.PubMedCrossRefGoogle Scholar
  25. 25.
    Adams SJ, Davison AM, Cunliffe WJ, Giles GR. Perioral dermatitis in renal transplant recipients maintained on corticosteroids and immunosuppressive therapy. Br J Dermatol. 1982;106(5):589–92.PubMedCrossRefGoogle Scholar
  26. 26.
    Hogan DJ. Perioral dermatitis. Curr Probl Dermatol. 1995;22:98–104.PubMedGoogle Scholar
  27. 27.
    Rodriguez-Martin M, Saez-Rodriguez M, Carnerero-Rodriguez A, Rodriguez-Garcia F, Cabrera de Paz R, Sidro-Sarto M, et al. Treatment of perioral dermatitis with topical pimecrolimus. J Am Acad Dermatol. 2007;56(3):529–30.PubMedCrossRefGoogle Scholar
  28. 28.
    Goss JM, Nord KM, Olarte MR, Grossman ME. Perioral dermatitis in a patient with myasthenia gravis following systemic corticosteroid treatment. Br J Dermatol. 2007;156(3):582.PubMedCrossRefGoogle Scholar
  29. 29.
    Kuflik JH, Janniger CK, Piela Z. Perioral dermatitis: an acneiform eruption. Cutis. 2001;67(1):21–2.PubMedGoogle Scholar
  30. 30.
    Urbatsch AJ, Frieden I, Williams ML, Elewski BE, Mancini AJ, Paller AS. Extrafacial and generalized granulomatous periorificial dermatitis. Arch Dermatol. 2002;138(10):1354–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Hansen KK, McTigue MK, Esterly NB. Multiple facial, neck, and upper trunk papules in a black child. Childhood granulomatous perioral dermatitis with involvement of the neck and upper trunk. Arch Dermatol. 1992;128(10):1396–7, 9.Google Scholar
  32. 32.
    Frieden IJ, Prose NS, Fletcher V, Turner ML. Granulomatous perioral dermatitis in children. Arch Dermatol. 1989;125(3):369–73.PubMedCrossRefGoogle Scholar
  33. 33.
    Marks R, Black MM. Perioral dermatitis. A histopathologic study of 26 cases. Br J Dermatol. 1971;84(3):242–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Misago N, Nakafusa J, Narisawa Y. Childhood granulomatous periorificial dermatitis: lupus miliaris disseminatus faciei in children? J Eur Acad Dermatol Venereol. 2005;19(4):470–3.PubMedCrossRefGoogle Scholar
  35. 35.
    van de Scheur MR, van der Waal RI, Starink TM. Lupus miliaris disseminatus faciei: a distinctive rosacea-like syndrome and not a granulomatous form of rosacea. Dermatology. 2003;206(2):120–3.PubMedCrossRefGoogle Scholar
  36. 36.
    Moloney FJ, Egan CA. Case 3. Acne agminata (lupus miliaris disseminatus faciei). Clin Exp Dermatol. 2003;28(6):685–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–41 quiz 42-4.PubMedCrossRefGoogle Scholar
  38. 38.
    Drolet B, Paller AS. Childhood rosacea. Pediatr Dermatol. 1992;9(1):22–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Smith KW. Perioral dermatitis with histopathologic features of granulomatous rosacea: successful treatment with isotretinoin. Cutis. 1990;46(5):413–5.PubMedGoogle Scholar
  40. 40.
    Khokhar O, Khachemoune A. A case of granulomatous rosacea: sorting granulomatous rosacea from other granulomatous diseases that affect the face. Dermatol Online J. 2004;10(1):6.PubMedGoogle Scholar
  41. 41.
    Kroshinsky D, Glick SA. Pediatric rosacea. Dermatol Ther. 2006;19(4):196–201.PubMedCrossRefGoogle Scholar
  42. 42.
    Tarm K, Creel NB, Krivda SJ, Turiansky GW. Granulomatous periorificial dermatitis. Cutis. 2004;73(6):399–402.PubMedGoogle Scholar
  43. 43.
    Williams HC, Ashworth J, Pembroke AC, Breathnach SM. FACE—facial Afro-Caribbean childhood eruption. Clin Exp Dermatol. 1990;15(3):163–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Knautz MA, Lesher JL Jr. Childhood granulomatous periorificial dermatitis. Pediatr Dermatol. 1996;13(2):131–4.PubMedCrossRefGoogle Scholar
  45. 45.
    Nedorost ST. Medical Pearl: the evaluation of perioral dermatitis: use of an extended patch test series. J Am Acad Dermatol. 2007;56(5 Suppl):S100–2.PubMedCrossRefGoogle Scholar
  46. 46.
    Wilkinson DS, Kirton V, Wilkinson JD. Perioral dermatitis: a 12-year review. Br J Dermatol. 1979;101(3):245–57.PubMedCrossRefGoogle Scholar
  47. 47.
    Dirschka T, Weber K, Tronnier H. Topical cosmetics and perioral dermatitis. J Dtsch Dermatol Ges. 2004;2(3):194–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Frumess GM, Lewis HM. Light-sensitive seborrheid. AMA Arch Derm. 1957;75(2):245–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Miller WS. Tetracycline in the treatment of perioral dermatitis. N C Med J. 1971;32(11):471–2.PubMedGoogle Scholar
  50. 50.
    Macdonald A, Feiwel M. Perioral dermatitis: aetiology and treatment with tetracycline. Br J Dermatol. 1972;87(4):315–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Sneddon I. Perioral dermatitis. Br J Dermatol. 1972;87(5):430–4.PubMedCrossRefGoogle Scholar
  52. 52.
    Sneddon I. A trial of hydrocortisone butyrate in the treatment of rosacea and perioral dermatitis. Br J Dermatol. 1973;89(5):505–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Bendl BJ. Perioral dermatitis: etiology and treatment. Cutis. 1976;17(5):903–8.PubMedGoogle Scholar
  54. 54.
    Urabe H, Koda H. Perioral dermatitis and rosacea-like dermatitis: clinical features and treatment. Dermatologica. 1976;152(Suppl 1):155–60.PubMedCrossRefGoogle Scholar
  55. 55.
    Cochran RE, Thomson J. Perioral dermatitis: a reappraisal. Clin Exp Dermatol. 1979;4(1):75–80.PubMedCrossRefGoogle Scholar
  56. 56.
    Cotterill JA. Perioral dermatitis. Br J Dermatol. 1979;101(3):259–62.PubMedCrossRefGoogle Scholar
  57. 57.
    Wilson RG. Topical tetracycline in the treatment of perioral dermatitis. Arch Dermatol. 1979;115(5):637.PubMedCrossRefGoogle Scholar
  58. 58.
    Bikowski JB. Topical therapy for perioral dermatitis. Cutis. 1983;31(6):678–82.PubMedGoogle Scholar
  59. 59.
    Coskey RJ. Perioral dermatitis. Cutis. 1984;34(1):55–6, 8.Google Scholar
  60. 60.
    Veien NK, Munkvad JM, Nielsen AO, Niordson AM, Stahl D, Thormann J. Topical metronidazole in the treatment of perioral dermatitis. J Am Acad Dermatol. 1991;24(2 Pt 1):258–60.PubMedCrossRefGoogle Scholar
  61. 61.
    Manders SM, Lucky AW. Perioral dermatitis in childhood. J Am Acad Dermatol. 1992;27(5 Pt 1):688–92.PubMedCrossRefGoogle Scholar
  62. 62.
    Weber K, Thurmayr R. A topical erythromycin preparation and oral tetracycline for the treatment of perioral dermatitis: a placebo-controlled trial. J Dermatol Treat. 1993;4:57–9.CrossRefGoogle Scholar
  63. 63.
    Boeck K, Abeck D, Werfel S, Ring J. Perioral dermatitis in children—clinical presentation, pathogenesis-related factors and response to topical metronidazole. Dermatology. 1997;195(3):235–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Weber K. How I treat perioral dermatitis: non-compliance with the treatment guidelines. Dermatology. 2003;207(2):215.PubMedCrossRefGoogle Scholar
  65. 65.
    Jansen T. Azelaic acid as a new treatment for perioral dermatitis: results from an open study. Br J Dermatol. 2004;151(4):933–4.PubMedCrossRefGoogle Scholar
  66. 66.
    Richey DF, Hopson B. Photodynamic therapy for perioral dermatitis. J Drugs Dermatol. 2006;5(2 Suppl):12–6.PubMedGoogle Scholar
  67. 67.
    Oppel T, Pavicic T, Kamann S, Brautigam M, Wollenberg A. Pimecrolimus cream (1%) efficacy in perioral dermatitis—results of a randomized, double-blind, vehicle-controlled study in 40 patients. J Eur Acad Dermatol Venereol. 2007;21(9):1175–80.PubMedGoogle Scholar
  68. 68.
    Schwarz T, Kreiselmaier I, Bieber T, Thaci D, Simon JC, Meurer M, et al. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. J Am Acad Dermatol. 2008;59(1):34–40.PubMedCrossRefGoogle Scholar
  69. 69.
    Kihiczak GG, Cruz MA, Schwartz RA. Periorificial dermatitis in children: an update and description of a child with striking features. Int J Dermatol. 2009;48(3):304–6.PubMedCrossRefGoogle Scholar
  70. 70.
    Jansen T, Melnik BC, Schadendorf D. Steroid-induced periorificial dermatitis in children—clinical features and response to azelaic acid. Pediatr Dermatol. 2010;27(2):137–42.PubMedCrossRefGoogle Scholar
  71. 71.
    Ishiguro N, Maeda A, Suzuki K, Yamana Y, Fukuya Y, Kawashima M. Three cases of perioral dermatitis related to fusobacteria treated with beta-lactam antibiotics. J Dermatolog Treat. 2014;25(6):507–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Miller SR, Shalita AR. Topical metronidazole gel (0.75%) for the treatment of perioral dermatitis in children. J Am Acad Dermatol. 1994;31(5 Pt 2):847–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Zalaudek I, Di Stefani A, Ferrara G, Argenziano G. Childhood granulomatous periorificial dermatitis: a controversial disease. J Dtsch Dermatol Ges. 2005;3(4):252–5.PubMedCrossRefGoogle Scholar
  74. 74.
    Choi YL, Lee KJ, Cho HJ, Kim WS, Lee JH, Yang JM, et al. Case of childhood granulomatous periorificial dermatitis in a Korean boy treated by oral erythromycin. J Dermatol. 2006;33(11):806–8.PubMedCrossRefGoogle Scholar
  75. 75.
    Hussain W, Daly BM. Granulomatous periorificial dermatitis in an 11-year-old boy: dramatic response to tacrolimus. J Eur Acad Dermatol Venereol. 2007;21(1):137–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Ahmed I. Clinicopathologic challenge. Childhood granulomatous peri-orificial dermatitis with extra-facial lesions. Int J Dermatol. 2007;46(2):143–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Rodriguez-Caruncho C, Bielsa I, Fernandez-Figueras MT, Ferrandiz C. Childhood granulomatous periorificial dermatitis with a good response to oral metronidazole. Pediatr Dermatol. 2013;30(5):e98–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Ellis CN, Stawiski MA. The treatment of perioral dermatitis, acne rosacea, and seborrheic dermatitis. Med Clin North Am. 1982;66(4):819–30.PubMedGoogle Scholar
  79. 79.
    Bikowski JB. Treatment of rosacea with doxycycline monohydrate. Cutis. 2000;66(2):149–52.PubMedGoogle Scholar
  80. 80.
    Bornhovd EC, Burgdorf WH, Wollenberg A. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases. Curr Opin Investig Drugs. 2002;3(5):708–12.PubMedGoogle Scholar
  81. 81.
    Schuller E, Oppel T, Bornhovd E, Wetzel S, Wollenberg A. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis. J Allergy Clin Immunol. 2004;114(1):137–43.PubMedCrossRefGoogle Scholar
  82. 82.
    Hoetzenecker W, Ecker R, Kopp T, Stuetz A, Stingl G, Elbe-Burger A. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. J Allergy Clin Immunol. 2005;115(6):1276–83.PubMedCrossRefGoogle Scholar
  83. 83.
    Akamatsu H, Komura J, Asada Y, Miyachi Y, Niwa Y. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res. 1991;283(3):162–6.PubMedCrossRefGoogle Scholar
  84. 84.
    Tarimci N, Sener S, Kilinc T. Topical sodium sulfacetamide/sulfur lotion. J Clin Pharm Ther. 1997;22(4):301.PubMedCrossRefGoogle Scholar
  85. 85.
    Sauder D, Miller R, Gratton D. The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion is demonstrated in a double blind study. J Dermatolog Treat. 1997;8:79–85.CrossRefGoogle Scholar
  86. 86.
    Nally JB, Berson DS. Topical therapies for rosacea. J Drugs Dermatol. 2006;5(1):23–6.PubMedGoogle Scholar
  87. 87.
    Olansky S. Old drug—in a new system—revisited. Cutis. 1977;19(6):852–4.PubMedGoogle Scholar
  88. 88.
    Mackley CL, Thiboutot DM. Diagnosing and managing the patient with rosacea. Cutis. 2005;75(4 Suppl):25–9.PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.Department of Pediatrics, Faculty of MedicineChulalongkorn UniversityBangkokThailand
  2. 2.Department of DermatologyHenry Ford HospitalDetroitUSA

Personalised recommendations